Japanese pharma company wins arbitration over cancer drug
Dispute over the Enhertu began in 2019 | Antibody drug conjugate tech at issue | American Arbitration Association issued final decision.
Fed Circuit rejects Minerva patent invalidation bid
Hologic patent invented by Minerva’s founder cannot be invalidated | Patent in dispute concerns device used to treat uterine bleeding | US Court of Appeals.
Hemp group in cybersquatting clash
Illinois-based firm accuses hemp group of cybersquatting | US Court for the District of Colorado.
Rival sues Monsanto, Bayer over GM plant tech
Firms accused of using GM tech for herbicide-resistant plants | Plaintiff says its patented tech helps farmers to innovate | US District Court for the District of Delaware.
Chugai settles cancer drug patent dispute with US firm
Parties to withdraw lawsuit over lung cancer drug | ANDA generic would have displaced sales of patented version in Delaware, said plaintiff.
UK pharma firm ‘stole’ psilocybin secrets from professor
Mental health specialists in dispute over psilocybin | Terran Biosciences accuses Compass Pathways of ‘milking’ professor before ‘secretly’ filing a patent for the medicine.
Pfizer bolsters haematology expertise with $5.4bn deal
Pharma giant to acquire biopharma firm specialising in sickle cell treatment | Key treatment will be distributed to countries most impacted by the disease.
Amgen continues M&A flurry with $3.7bn deal
Pharma company to acquire biopharma focused on autoimmune, inflammatory and cancer therapeutics / Deal includes acquisition of Tavneos / Spate of acquisitions follows increased competition.
US govt loses appeal in GSK trade secret suit
Trade secret suit allegedly cost the pharma company over $1bn | Chinese researcher who stole approximately 200 GSK documents avoids paying restitution | Economic warfare.
J&J unit primed for multi-million dollar damages over counterfeits
Judge urges $18m award in ‘horrific’ counterfeiting case | Counterfeits were ‘bacterially contaminated’ | Ethicon.
